Articles published by AstraZeneca![]()
FASENRA met the primary endpoint in the MANDARA Phase III trial in eosinophilic granulomatosis with polyangiitis (EGPA)
September 11, 2023
From AstraZeneca
Via Business Wire
Tickers
AZN
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
AstraZeneca announces innovative partnership with Vanguard Renewables to decarbonize its United States sites
June 13, 2023
From AstraZeneca
Via Business Wire
Tickers
AZN
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|